300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Photography
Restaurants
Email
Payments
Energy
CleanTech
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Automotive
Mobile
Hospitality
Biotechnology
Consumer
Sports
Legal
Software
Renewable Energy
eSports
Crowdfunding
Theatre
Medical
Recruiting
Construction
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Art
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Real Estate
Sporting Goods
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Nigeria
Tajikistan
Russian Federation
Togo
Guinea
Nepal
Iran
Madagascar
Isle of Man
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Turkey
Malawi
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
United Kingdom
Ghana
Iraq
Mali
Malaysia
Latvia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bangladesh
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Hans Tai is a funding round investor at ITIC: Industrial Technology Investment Corporation focused on Medical and Marketing. Mr. Hans Tai serves as President at Industrial Technology Investment Corporation. From 2014 to 2017, Mr. Tai served as Chairman at Cuiqin Communication Co., Ltd. From 2012 to 2017, he served as Chairman at Xinqiao Lianhe Venture Capital Co., Ltd. From 2010 to 2013, Mr. Tai served as Chairman at the Shanghai Office, Youyoucun Network Co., Ltd. From2010 to 2017, he served as General Manager at InnoBridge International Inc. From 2000 to 2009, Mr.Tai served as Investment Officer at Lingyang Technology Co., Ltd. and General Manager at Lingyang Venture Capital Co., Ltd. From 1997 to 2010, he served as Fund Manager at Debang Venture Capital Co., Ltd. Mr. Tai obtained his Master's in Engineering from University of Toronto in 1996. He obtained his Bachelor's degree from National Chiao Tung University in 1992.

Total investments:
4
Last investment:
Lead investor:
75%

Last updated:

Industries Hans Tai invests in

MedicalMarketingIndustrialHealth CareBiotechnology

Stages Hans Tai invests in

Funding RoundSeries AVenture - Series Unknown

Countries Hans Tai invests in

JapanUnited States

Investment Focus

Industry

  • Medical 1 (25%)
  • Marketing 1 (25%)
  • Industrial 1 (25%)
  • Health Care 1 (25%)
  • Biotechnology 1 (25%)
See all 6 industries →

Stage

  • Funding Round 2 (50%)
  • Series A 1 (25%)
  • Venture - Series Unknown 1 (25%)

Country

  • Japan 1 (25%)
  • United States 1 (25%)

Investments

CompanyDescriptionRoundLinks
Cellusion Cellusion
Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system. $15.6M / May 31, 2020
Cellusion Cellusion
Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system. $1M / Series A / May 31, 2020
nanoGriptech nanoGriptech
NanoGriptech has developed a nature-inspired microfiber based adhesive that functions in the same way a gecko’s feet stick to surfaces. As a dry, durable, residue-free, and customizable adhesive, nanoGriptech’s product provides a superior alternative to reusable adhesives currently being used in a large variety of industries such as clothing,sports, automotive, product design, and medical devices.The company has successfully engaged in partnerships with several multinational corporations across these industries and just started its first small volume sale in high friction/grip clothing material market. $6M / Venture - Series Unknown / Mar 12, 2020
nanoGriptech nanoGriptech
NanoGriptech has developed a nature-inspired microfiber based adhesive that functions in the same way a gecko’s feet stick to surfaces. As a dry, durable, residue-free, and customizable adhesive, nanoGriptech’s product provides a superior alternative to reusable adhesives currently being used in a large variety of industries such as clothing,sports, automotive, product design, and medical devices.The company has successfully engaged in partnerships with several multinational corporations across these industries and just started its first small volume sale in high friction/grip clothing material market. $1.7M / Dec 12, 2018

Co-Investors

ITIC: Industrial Technology Investment Corporation

About ITIC: Industrial Technology Investment Corporation

VC Fund · Taipei, Taiwan

We are the venture capital arm of the renowned R&D consortium – the Industrial Technology Research Institute (ITRI). Since our creation in 1979, we have invested over US$400 million across virtually all stages, sectors, and timezones. Companies we have nurtured have gone on to define entire industries, and boast a combined market cap of wellover US$200 billion. Since its inception, ITIC has been instrumental in leading Taiwan's initial ventures into technology-based businesses, such as integrated circuits, automation, opto-electronic display, etc. ITIC is an original shareholder of some industry leaders such as UMC, Taiwan Mask Corp., Acer Display Technologies, Inc.(renamed as AU Optronics Corp.).

ITIC: Industrial Technology Investment Corporation Contacts

NameEmailPhoneSocials
Hans Tai President

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Open ITIC: Industrial Technology Investment Corporation full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Photography
Restaurants
Email
Payments
Energy
CleanTech
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Automotive
Mobile
Hospitality
Biotechnology
Consumer
Sports
Legal
Software
Renewable Energy
eSports
Crowdfunding
Theatre
Medical
Recruiting
Construction
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Art
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Real Estate
Sporting Goods
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Nigeria
Tajikistan
Russian Federation
Togo
Guinea
Nepal
Iran
Madagascar
Isle of Man
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Turkey
Malawi
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
United Kingdom
Ghana
Iraq
Mali
Malaysia
Latvia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bangladesh
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Hans Tai invest in?

Hans Tai invests primarily in Medical, Marketing and Industrial startups, most often at Funding Round and Series A stage. Most of the 4 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Hans Tai last invest?

The most recent investment recorded for Hans Tai closed in May 2020. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Hans Tai Find email